BOSTON, April 25, 2024--PureTech Announces Annual Results for Year Ended December 31, 2023
BOSTON, April 18, 2024--PureTech Health: Notice of Results
BOSTON, April 16, 2024--PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis